Compound genetic etiology in a patient with a syndrome including diabetes, intellectual deficiency and distichiasis.
Childhood onset diabetes
Genetic analysis
Genetic disorders
Genotype–phenotype relations
Intellectual disability
Wolfram syndrome
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
28 02 2022
28 02 2022
Historique:
received:
25
08
2021
accepted:
13
02
2022
entrez:
1
3
2022
pubmed:
2
3
2022
medline:
14
4
2022
Statut:
epublish
Résumé
We studied a young woman with atypical diabetes associated with mild intellectual disability, lymphedema distichiasis syndrome (LDS) and polymalformative syndrome including distichiasis. We used different genetic tools to identify causative pathogenic mutations and/or copy number variations. Although proband's, diabetes mellitus occurred during childhood, type 1 diabetes was unlikely due to the absence of detectable autoimmunity. DNA microarray analysis first identified a de novo, heterozygous deletion at the chr16q24.2 locus. Previously, thirty-three pathogenic or likely pathogenic deletions encompassing this locus have been reported in patients presenting with intellectual deficiency, obesity and/or lymphedema but not with diabetes. Of note, the deletion encompassed two topological association domains, whose one included FOXC2 that is known to be linked with LDS. Via whole-exome sequencing, we found a heterozygous, likely pathogenic variant in WFS1 (encoding wolframin endoplasmic reticulum [ER] transmembrane glycoprotein) which was inherited from her father who also had diabetes. WFS1 is known to be involved in monogenic diabetes. We also found a likely pathogenic variant in USP9X (encoding ubiquitin specific peptidase 9 X-linked) that is involved in X-linked intellectual disability, which was inherited from her mother who had dyscalculia and dyspraxia. Our comprehensive genetic analysis suggested that the peculiar phenotypes of our patient were possibly due to the combination of multiple genetic causes including chr16q24.2 deletion, and two likely pathogenic variants in WFS1 and USP9X.
Sections du résumé
BACKGROUND
We studied a young woman with atypical diabetes associated with mild intellectual disability, lymphedema distichiasis syndrome (LDS) and polymalformative syndrome including distichiasis. We used different genetic tools to identify causative pathogenic mutations and/or copy number variations.
RESULTS
Although proband's, diabetes mellitus occurred during childhood, type 1 diabetes was unlikely due to the absence of detectable autoimmunity. DNA microarray analysis first identified a de novo, heterozygous deletion at the chr16q24.2 locus. Previously, thirty-three pathogenic or likely pathogenic deletions encompassing this locus have been reported in patients presenting with intellectual deficiency, obesity and/or lymphedema but not with diabetes. Of note, the deletion encompassed two topological association domains, whose one included FOXC2 that is known to be linked with LDS. Via whole-exome sequencing, we found a heterozygous, likely pathogenic variant in WFS1 (encoding wolframin endoplasmic reticulum [ER] transmembrane glycoprotein) which was inherited from her father who also had diabetes. WFS1 is known to be involved in monogenic diabetes. We also found a likely pathogenic variant in USP9X (encoding ubiquitin specific peptidase 9 X-linked) that is involved in X-linked intellectual disability, which was inherited from her mother who had dyscalculia and dyspraxia.
CONCLUSIONS
Our comprehensive genetic analysis suggested that the peculiar phenotypes of our patient were possibly due to the combination of multiple genetic causes including chr16q24.2 deletion, and two likely pathogenic variants in WFS1 and USP9X.
Identifiants
pubmed: 35227307
doi: 10.1186/s13023-022-02248-2
pii: 10.1186/s13023-022-02248-2
pmc: PMC8887189
doi:
Substances chimiques
USP9X protein, human
0
Ubiquitin Thiolesterase
EC 3.4.19.12
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
86Informations de copyright
© 2022. The Author(s).
Références
Nucleus. 2018 Jan 1;9(1):20-32
pubmed: 29077530
J Med Genet. 2013 Mar;50(3):163-73
pubmed: 23335808
Lancet. 2014 Jan 4;383(9911):69-82
pubmed: 23890997
J Diabetes. 2016 Nov;8(6):782-795
pubmed: 27390143
Acta Paediatr. 2000 Jan;89(1):46-51
pubmed: 10677057
Am J Med Genet A. 2014 Aug;164A(8):2062-8
pubmed: 24719385
Pediatr Nephrol. 2016 May;31(5):707-14
pubmed: 26160100
Genome Med. 2019 Jul 24;11(1):44
pubmed: 31340865
Diabetes. 2013 Nov;62(11):3943-50
pubmed: 23903355
Diabetes Metab. 1997 Apr;23(2):155-60
pubmed: 9137905
J Cell Mol Med. 2021 Feb;25(3):1406-1414
pubmed: 33345444
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Diabetes Res Clin Pract. 2021 Jan;171:108553
pubmed: 33242514
Sci Rep. 2018 Jul 5;8(1):10183
pubmed: 29976929
Diabetes Care. 2019 Feb;42(2):248-257
pubmed: 30552135
Nat Metab. 2020 Oct;2(10):1126-1134
pubmed: 33046911
Genome Biol. 2018 Oct 4;19(1):151
pubmed: 30286773
Diabetologia. 2018 Oct;61(10):2189-2201
pubmed: 30054673
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Clin Endocrinol Metab. 1999 Apr;84(4):1165-71
pubmed: 10199747
Am J Hum Genet. 2014 Mar 6;94(3):470-8
pubmed: 24607389
Trends Genet. 2016 Apr;32(4):225-237
pubmed: 26862051
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Cell Metab. 2015 Mar 3;21(3):357-68
pubmed: 25640731
Am J Med Genet A. 2021 Jan;185(1):150-156
pubmed: 33107170
Am J Hum Genet. 2016 Feb 4;98(2):373-81
pubmed: 26833328
Am J Med Genet A. 2012 Apr;158A(4):839-49
pubmed: 22407726
Nature. 2016 Oct 27;538(7626):523-527
pubmed: 27760116
Horm Res Paediatr. 2020;93(6):409-414
pubmed: 33075784
Lancet Diabetes Endocrinol. 2018 Nov;6(11):891-900
pubmed: 29699867
NPJ Genom Med. 2020 Dec 9;5(1):53
pubmed: 33298948